These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 2971547)

  • 1. Decreased prostacyclin sensitivity of platelets in patients with Behçet's syndrome.
    Wilson AP; Efthimiou J; Betteridge DJ
    Eur J Clin Invest; 1988 Aug; 18(4):410-4. PubMed ID: 2971547
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced platelet release reaction, shortened platelet survival time and increased platelet aggregation and plasma thromboxane B2 in chronic obstructive arterial disease.
    Zahavi J; Zahavi M
    Thromb Haemost; 1985 Feb; 53(1):105-9. PubMed ID: 3158092
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systemic and transcardiac platelet activity in acute myocardial infarction in man: resistance to prostacyclin.
    Mueller HS; Rao PS; Greenberg MA; Buttrick PM; Sussman II; Levite HA; Grose RM; Perez-Davila V; Strain JE; Spaet TH
    Circulation; 1985 Dec; 72(6):1336-45. PubMed ID: 2933181
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stimulated platelet aggregation, thromboxane B2 formation and platelet sensitivity to prostacyclin - a critical evaluation.
    Siess W; Roth P; Weber PC
    Thromb Haemost; 1981 Jun; 45(3):204-7. PubMed ID: 7025338
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Platelet hyperactivity in acute myocardial infarction in man--effects of prostacyclin.
    Mueller HS; Rao PS; Greenberg MA; Buttrick PM; Sussman II; Levite HA; Grose RM; Perez-Davila V; Strain JE; Spaet TH
    Herz; 1986 Apr; 11(2):116-26. PubMed ID: 2939012
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Platelet activation during steady state sickle cell disease.
    Westwick J; Watson-Williams EJ; Krishnamurthi S; Marks G; Ellis V; Scully MF; White JM; Kakkar VV
    J Med; 1983; 14(1):17-36. PubMed ID: 6224876
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of platelet function in patients with Raynaud's syndrome.
    Hutton RA; Mikhailidis DP; Bernstein RM; Jeremy JY; Hughes GR; Dandona P
    J Clin Pathol; 1984 Feb; 37(2):182-7. PubMed ID: 6229551
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Simvastatin reduces platelet thromboxane formation and restores normal platelet sensitivity against prostacyclin in type IIa hypercholesterolemia.
    Schrör K; Löbel P; Steinhagen-Thiessen E
    Eicosanoids; 1989; 2(1):39-45. PubMed ID: 2483819
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Platelet function, blood coagulation and fibrinolysis in Behcet's syndrome.
    Stathakis NE; Economopoulos TC; Papayannis AG; Thomopoulos D
    Blut; 1977 Mar; 34(3):215-22. PubMed ID: 843627
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Might platelet-leucocyte complexes be playing a role in major vascular involvement of Behçet's disease? A comparative study.
    Pamuk GE; Pamuk ON; Orüm H; Demir M; Turgut B; Cakir N
    Blood Coagul Fibrinolysis; 2010 Mar; 21(2):113-7. PubMed ID: 20135752
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Organic nitrates: direct antiplatelet effects and synergism with prostacyclin. Antiplatelet effects of organic nitrates.
    De Caterina R; Giannessi D; Bernini W; Mazzone A
    Thromb Haemost; 1988 Apr; 59(2):207-11. PubMed ID: 3291182
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Platelet function in hypercholesterolemics before and after hypolipidemic drug therapy.
    Zucker ML; Trowbridge C; Krehbiel P; Jackson B; Chernoff SB; Dujovne CA
    Haemostasis; 1986; 16(1):57-64. PubMed ID: 2939008
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biological actions of prostacyclin and its pharmacological use in platelet studies.
    Moncada S; Whittle BJ
    Adv Exp Med Biol; 1985; 192():337-58. PubMed ID: 3010671
    [No Abstract]   [Full Text] [Related]  

  • 14. Enhanced platelet sensitivity to prostacyclin in patients in an active stage of Takayasu arteritis.
    Watanabe T; Kishi Y; Numano F; Isobe M
    Thromb Res; 2001 Oct; 104(2):77-83. PubMed ID: 11672751
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of arterial thrombosis and platelet function by nafazatrom.
    Buchanan MR; Blajchman M; Hirsh J
    Thromb Res; 1982 Oct; 28(2):157-70. PubMed ID: 6758186
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced platelet sensitivity to prostacyclin after isosorbide-5-mononitrate in patients with stable angina pectoris.
    Davì G; Cannizzaro S; Giubilato A; Novo S; Mattina A; Strano A
    Z Kardiol; 1986; 75 Suppl 3():80-2. PubMed ID: 3541421
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prostacyclin prolongs viability of washed human platelets.
    Blackwell GJ; Radomski M; Vargas JR; Moncada S
    Biochim Biophys Acta; 1982 Sep; 718(1):60-5. PubMed ID: 6291622
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Paradoxical platelet behaviour in diabetic ketoacidosis.
    Campbell RR; Foster KJ; Stirling C; Mundy D; Reckless JP
    Diabet Med; 1986 Mar; 3(2):161-4. PubMed ID: 2951159
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Platelet function studies during and after infusions of ZK 36374, a stable prostacyclin analogue, to healthy volunteers.
    Yardumian DA; Mackie IJ; Brennan EC; Bull H; Machin SJ
    Haemostasis; 1986; 16(1):20-6. PubMed ID: 2422095
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does acute experimental pancreatitis affect blood platelet function?
    Lukaszyk A; Bodzenta-Lukaszyk A; Gabryelewicz A; Bielawiec M
    Thromb Res; 1989 Feb; 53(3):319-25. PubMed ID: 2524119
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.